Verrica Pharmaceuticals Inc
NASDAQ:VRCA
Verrica Pharmaceuticals Inc
NASDAQ:VRCA
Price:
5.74
USD
2.68%
Market Cap:
$91.8m
Income Statement
Earnings Waterfall
Verrica Pharmaceuticals Inc
Verrica Pharmaceuticals Inc
Income Statement
Verrica Pharmaceuticals Inc
Verrica Pharmaceuticals Inc
Currency: USD
| Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
3
|
2
|
0
|
0
|
2
|
4
|
6
|
9
|
9
|
9
|
9
|
9
|
9
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
12
N/A
|
12
N/A
|
12
N/A
|
12
N/A
|
0
-96%
|
1
+49%
|
9
+1 300%
|
9
+1%
|
9
-4%
|
9
0%
|
3
-63%
|
5
+60%
|
9
+74%
|
14
+56%
|
9
-34%
|
8
-18%
|
7
-5%
|
15
+105%
|
31
+110%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
(3)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
8
N/A
|
(1)
N/A
|
(1)
+7%
|
2
N/A
|
4
+118%
|
7
+62%
|
12
+65%
|
7
-42%
|
5
-29%
|
5
+7%
|
13
+147%
|
28
+122%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||
| Operating Expenses |
(4)
|
(6)
|
(10)
|
(15)
|
(22)
|
(26)
|
(29)
|
(29)
|
(30)
|
(32)
|
(33)
|
(36)
|
(40)
|
(42)
|
(44)
|
(46)
|
(43)
|
(39)
|
(37)
|
(33)
|
(30)
|
(30)
|
(33)
|
(51)
|
(68)
|
(84)
|
(92)
|
(84)
|
(71)
|
(60)
|
(52)
|
(45)
|
|
| Selling, General & Administrative |
(1)
|
(2)
|
(3)
|
(6)
|
(9)
|
(10)
|
(12)
|
(13)
|
(15)
|
(16)
|
(18)
|
(19)
|
(25)
|
(26)
|
(28)
|
(32)
|
(27)
|
(26)
|
(23)
|
(19)
|
(17)
|
(17)
|
(17)
|
(34)
|
(47)
|
(59)
|
(70)
|
(66)
|
(59)
|
(52)
|
(44)
|
(37)
|
|
| Research & Development |
(4)
|
(4)
|
(7)
|
(9)
|
(13)
|
(16)
|
(17)
|
(16)
|
(15)
|
(16)
|
(15)
|
(17)
|
(16)
|
(16)
|
(16)
|
(15)
|
(16)
|
(13)
|
(14)
|
(13)
|
(12)
|
(12)
|
(14)
|
(17)
|
(20)
|
(23)
|
(20)
|
(16)
|
(12)
|
(9)
|
(8)
|
(8)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(4)
N/A
|
(6)
-30%
|
(10)
-75%
|
(15)
-49%
|
(22)
-45%
|
(26)
-21%
|
(29)
-8%
|
(29)
-1%
|
(30)
-5%
|
(32)
-6%
|
(33)
-3%
|
(36)
-9%
|
(40)
-11%
|
(30)
+25%
|
(32)
-7%
|
(34)
-7%
|
(31)
+10%
|
(38)
-24%
|
(37)
+4%
|
(24)
+36%
|
(21)
+10%
|
(22)
-5%
|
(25)
-11%
|
(49)
-96%
|
(63)
-29%
|
(77)
-22%
|
(81)
-4%
|
(78)
+4%
|
(66)
+15%
|
(56)
+16%
|
(39)
+30%
|
(16)
+58%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
0
|
(1)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(2)
|
(0)
|
1
|
1
|
(1)
|
(3)
|
(6)
|
(7)
|
(11)
|
(11)
|
(10)
|
(10)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(4)
N/A
|
(6)
-29%
|
(10)
-73%
|
(15)
-46%
|
(21)
-42%
|
(25)
-20%
|
(26)
-7%
|
(27)
-1%
|
(28)
-6%
|
(31)
-8%
|
(33)
-8%
|
(37)
-13%
|
(43)
-14%
|
(34)
+21%
|
(36)
-7%
|
(39)
-6%
|
(35)
+9%
|
(43)
-21%
|
(41)
+4%
|
(28)
+31%
|
(24)
+13%
|
(23)
+8%
|
(23)
-4%
|
(48)
-106%
|
(67)
-39%
|
(81)
-21%
|
(87)
-7%
|
(85)
+2%
|
(77)
+10%
|
(66)
+14%
|
(49)
+26%
|
(26)
+47%
|
|
| Net Income | |||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(4)
|
(6)
|
(10)
|
(15)
|
(21)
|
(25)
|
(26)
|
(27)
|
(28)
|
(31)
|
(33)
|
(37)
|
(43)
|
(34)
|
(36)
|
(39)
|
(35)
|
(43)
|
(41)
|
(28)
|
(24)
|
(23)
|
(23)
|
(48)
|
(67)
|
(81)
|
(87)
|
(85)
|
(77)
|
(66)
|
(49)
|
(26)
|
|
| Net Income (Common) |
(4)
N/A
|
(6)
-29%
|
(10)
-73%
|
(15)
-46%
|
(21)
-42%
|
(25)
-20%
|
(26)
-7%
|
(27)
-1%
|
(28)
-6%
|
(31)
-8%
|
(33)
-8%
|
(37)
-13%
|
(43)
-14%
|
(34)
+21%
|
(36)
-7%
|
(39)
-6%
|
(35)
+9%
|
(43)
-21%
|
(41)
+4%
|
(28)
+31%
|
(24)
+13%
|
(23)
+8%
|
(23)
-4%
|
(48)
-106%
|
(67)
-39%
|
(81)
-21%
|
(87)
-7%
|
(85)
+2%
|
(77)
+10%
|
(66)
+14%
|
(49)
+26%
|
(26)
+47%
|
|
| EPS (Diluted) |
-1.78
N/A
|
-2.31
-30%
|
-3.87
-68%
|
-5.83
-51%
|
-8
-37%
|
-9.96
-25%
|
-10.64
-7%
|
-10.7
-1%
|
-11.33
-6%
|
-12.23
-8%
|
-13.2
-8%
|
-14.95
-13%
|
-17.07
-14%
|
-13.2
+23%
|
-13.15
+0%
|
-14
-6%
|
-12.97
+7%
|
-15.48
-19%
|
-14.9
+4%
|
-6.29
+58%
|
-7.16
-14%
|
-5.25
+27%
|
-5.1
+3%
|
-10.48
-105%
|
-14.78
-41%
|
-17.36
-17%
|
-18.65
-7%
|
-18.14
+3%
|
-14.78
+19%
|
-6.95
+53%
|
-5.13
+26%
|
-2.74
+47%
|
|
Switch to:
Switch to:
See Also
Discover More
